Berkeley Capital Partners’s Sanofi SNY Stock Holding History

Berkeley Capital Partners’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-7,966	Closed	-$322K	–	122
2016 Q4	$322K	Sell	7,966 -3,596	-31%	-$142K	0.23%	87
2016 Q3	$442K	Buy	+11,562	New	+$464K	0.32%	69

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Berkeley Capital Partners's SNY Position: Q1 2017 in Review

Berkeley Capital Partners sold out of Sanofi (SNY) in Q1 2017, closing a stake of 7,966 shares — an estimated $322K sold.

Berkeley Capital Partners first reported a position in SNY in Q3 2016 and held it in 2 quarters. The position peaked at $442K in Q3 2016. 455 funds tracked by Wall St. Rank hold SNY as of Q1 2017.

Berkeley Capital Partners reported no remaining Sanofi position as of Q1 2017 after selling out during the quarter.
Berkeley Capital Partners sold 7,966 Sanofi shares in Q1 2017, an estimated $322K.
Berkeley Capital Partners first reported a position in Sanofi in Q3 2016 and held it in 2 quarters.
Berkeley Capital Partners's Sanofi position peaked at $442K in Q3 2016.
455 funds tracked by Wall St. Rank held Sanofi as of Q1 2017.

Based on Berkeley Capital Partners's 13F filing for Q1 2017, filed 10 May 2017.